Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments

• Päätekijät: Rina Matsuoka (Tekijä), Shinsuke Akagi (Tekijä), Tomohiro Konishi (Tekijä), Masashi Kondo (Tekijä), Hideki Matsubara (Tekijä), Shohei Yamamoto (Tekijä), Keiji Izushi (Tekijä), Yuichi Tasaka (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2024-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Drug-drug interactions (DDIs) increase the incidence of adverse drug reactions (ADRs). In a previous report, we revealed that the incidence of potential DDIs due to the same CYP molecular species in one prescription exceeds 90% among patients taking six or more drugs and that CYP...